View Post

Savvy Cooperative: People who have been diagnosed with Breast, Colon, or Ovarian Cancer

In Paid Opportunities For The Cancer Community by Barbara Jacoby

SCREENER Eligibility Criteria: Adult who has been diagnosed with Breast, Colon, or Ovarian Cancer NOTE: Only patients with verified diagnoses will be considered US resident   Details: At home opportunity Receive: $110 USD per interview $55 USD per survey   Link: https://gigs.savvy.coop/bc-cc-oc/?r=44951 Why Sign Up? Your experiences are so valuable and important to creating better products and services, that companies …

View Post

Ancora.ai: New Jersey-Based Patients with cervical, ovarian, or uterine cancer

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Eligibility Criteria People living in New Jersey who have had treatment for cervical, ovarian, or uterine cancer in the past 2 years. Study Details 1-hour virtual interview conducted via computer Compensation $150 Link to Sign up https://www.surveymonkey.de/r/NJ_Women Why sign up with Ancora.ai?    Participating in research is an incredible way to share your personal opinions and insights to help improve cancer …

View Post

FDA Grants Fast-Track Designation to CX-5461 in Treatment of Certain Patients with Breast or Ovarian Cancer

In In The News by Barbara Jacoby

By: Conor Killmurray From: targetedonc.com The FDA has granted a fast-track designation to the G-quadruplex stabilizer CX-5461 for BRCA1/2, PALB2, or HRD mutations in their breast or ovarian cancer. The FDA granted a fast-track designation to the first-in-class G-quadruplex stabilizer CX-5461 (Pindnarulex) for the treatment of patients with BRCA1/2, PALB2, or other homologous recombination deficiency (HRD) mutations in their breast or ovarian …

View Post

Rare Patient Voice: Ovarian or Fallopian Tube Cancer Stage III or IV Patients

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Study Details: 25 min Online Survey Compensation $45 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are willing to pay $100 an hour for it! Signup Today and let YOUR Voice be heard! Why …

View Post

Rare Patient Voice: Study Opportunity for Ovarian Cancer Caregivers

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Study Details: A 75-minute Web-Assisted Phone Interview  Compensation $125 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are willing to pay $100 an hour for it! Signup Today and let YOUR Voice be heard! …

View Post

Rare Patient Voice: Study Opportunity for Ovarian Cancer Patients

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Study Details: 15 min Online Survey Compensation $25 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are willing to pay $100 an hour for it! Signup Today and let YOUR Voice be heard! Why …

View Post

Rare Patient Voice: Paid Opportunity for Ovarian Cancer Patients

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Study Details: 15 min Online Survey Compensation $25 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are willing to pay $100 an hour for it! Signup Today and let YOUR Voice be heard! Why …

View Post

Significant New Findings about Breast and Ovarian Cancer in Patients from the Caribbean

In In The News by Barbara Jacoby

By: University of Miami Health System, Miller School of Medicine From: newswise.com Judith Hurley, M.D., an oncologist and researcher at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has been studying racial disparities in breast cancer rates since 2002. After Dr. Hurley noticed that many of her Bahamian breast cancer patients were unusually young, she …

View Post

Rare Patient Voice: Ovarian Cancer Patients

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Study Details: 2 day Online Bulletin Board Compensation $100 Please sign up at the link below for more information or to see if you qualify. https://rarepatientvoice.com/LetLifeHappen/ Why Sign up with Rare Patient Voice? Who knows better than you about your journey and experiences?  We connect you with researchers who are developing products and services which can help you and others …

View Post

Popular breast cancer drugs don’t work the way we thought they did

In Clinical Studies News by Barbara Jacoby

By: Lisa Marshall From: colorado.edu Some of the most commonly used drugs for treating hereditary breast and ovarian cancers may not work the way we thought they did, according to new CU Boulder research. The paper, published Feb. 2 in the journal Nature Communications, sheds new light on how they do work and could open the door to new next-generation medications …